This latest announcement comes only a couple days after the Irvine, Calif.-based company that provides various services for the legal-marijuana industry announced that it acquired National Security Solutions.
Volkow’s qualifications in the Cyber-Security consist of a vast array of certifications and experience
-Federal TS/SCI Clearance since 2009
-Trained in intelligence analysis and analytic techniques.
-Served ODNI (Office of the Director of National Intelligence) Summer Hard Problem Program 2009 and 2010(UC) Product included recommendations on upgrades to the Presidents Daily Briefing (PDB).
-Participated in "Red Team" exercises involving exploiting mobile technology.
-Served ODNI as Producer for both (C) and (UC) briefing products.
-Co-Wrote analysis products on Social Media, Mixed Reality, Radicalization and De-radicalization.
-Co-Authored briefing papers for the Office of The Director of National Intelligence including (U) The Music of Terrorism, and Augmenting the Presidents Daily Briefing Process: Wisdom of Crowds Yielding Greater Analytic Collaboration (U).
-For DARPA he wrote the requirements for a comprehensive knowledge management / project management system focusing on DoD technology transition.
-Served an Analyst on DARPA Knowledge Management project from 2002-2004
-Over 10 years of technology management experience in the media sector.
-4 years of experience in mobile app development management and requirements planning.
-Served as Instructor at UCLA in digital technologies for over 10 years including as a lecturer at the Anderson Graduate School of Management and via the UCLA Extension.
-Enrolled in the 2014 USC Computer and Information Security Course delivered by the USC Information Sciences Institute (An NSA Center of Academic Excellence) and Los Angeles FBI office.
Few Details Given
National Security Solutions will focus primarily on the marijuana dispensaries and grow operations. However, CannaBusiness Group declined to reveal the specifics of the deal, or how it would affect its overall financial picture.
On Apr. 11, CBGI’s share price closed at 10 cents, down 2 cents, from its share price of 8 cents the previous day, on volume of 4.8-million shares.
Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:
http://www.pennypickalerts.com
FusionPharm Inc. To Release Delayed Financials Apr. 15
In other news, Commerce City, Colo-based FusionPharm Inc. (OTCPINK: FSPM), a company that makes and sells cultivation containers for marijuana growers, announced that it will release its delayed 2013 full-financial statements and related analysis Apr. 15, 2014.
According to FusionPharm, the delay in filing is the result of staffing limitations which were addressed in March.
This announcement comes only a week after the company said that it is set to ship its second Canadian order of 2014.
The initial order of approximately $270,000 worth of PharmPod containers is the first installment of an anticipated $2.3million, 12 month build-out of the Canadian facility. "The Canadian market has become our largest customer base so far in 2014 and we are excited to build the PharmPod brand in Canada and elsewhere." FusionPharm CEO Scott Dittman said, in a written statement.
FusionPharm is currently exploring sales and distribution partnership opportunities in Canada and intends to open a sales center in Canada in 2014.
This comes only days after FusionPharm announced that it has leased space in Seattle's SoDo warehouse district in anticipation of opening its first Washington State design and sales center later this spring.
Its stock volume and share value have been on a downward trend as of late, but there is no news indicating why this is the case. In fact, the company has been churning out a spate of positive news releases since the beginning of the year.
Doubled Manufacturing Square Footage
On Feb. 13, FusionPharm announced it had more than doubled its Denver Colorado area manufacturing facility, adding 10,000 additional square feet of manufacturing space. That’s because the company said that management felt that its existing manufacturing space was inadequate to handle current and future order flow effectively. The new facility is adjacent to the company's existing facility.
The company added that additional manufacturing facilities are planned for the east and west coast of the United States in 2014.
$1-Million Cash Infusion
Then on Feb 25, FusionPharm announced that it has completed a $1million round of equity funding. It said that management intended to use the funds to complete outfitting of its recently expanded manufacturing facilities, provide for construction of new sales centers in key markets and to provide operations funding for acquisition of key personnel.
On Apr. 11, FSPM’s share price closed at $3.15, down 41 cents from its closing price of $3.56 the previous day.
Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:
http://www.pennypickalerts.com
ABOUT US:
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com
Disclosure
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.